USPTO serial 76282447
SPOT
Reviewed by CopyMark Law Group
Reg. 2909434Status 710
- Filing date
- Status date
- Registration date
- Dec 14, 2004
- Examiner
- DEFORD, JEFFREY S
- Law office
- GENERIC WEB UPDATE
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SPOT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Berlin, DE
BERLIN, DE
BERLIN, DE
BERLIN, DE
Berlin, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Monica Riva Talley
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1101 K Street, NW10th FloorWashington, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemicals, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules for scientific and research use in the field of pharmaceuticals, food stuffs, plant protection, cosmetics, diagnostics and biochemical basic research; Immobilized chemical compounds, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules for scientific and research use in the field of pharmaceuticals, food stuffs, plant protection, cosmetics, diagnostics and biochemical basic research; libraries of immobilized chemical compounds, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules for scientific and research use in the field of pharmaceuticals, food stuffs, plant protection, cosmetics, diagnostics and biochemical basic research; Arrays of chemical compounds, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules for scientific and research use in the field of pharmaceuticals, food stuffs, plant protection, cosmetics, diagnostics and biochemical basic research; Arrays of libraries of chemical compounds, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules arranged on a support for scientific and research use in the field of pharmaceuticals, food stuffs, plant protection, cosmetics, diagnostics and biochemical basic research; Compounds, namely, peptides and peptidomimetrics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules which are generated using immobilized chemical compounds for scientific and research use in the field of pharmaceuticals, food stuffs, plant protection, cosmetics, diagnostics and biochemical basic research; Libraries of chemical compounds, namely, peptides and peptiomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules, preferably such compounds are immobilized and arrays of chemical compounds, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules or libraries of chemical compounds, all for use in the field of pharmaceuticals, food stuffs, plant protection, cosmetics, diagnostics and biochemical basic research] | SECTION 8 - CANCELLED | — |
| 005 | [ Pharmaceutical and veterinary preparations and sanitary preparations, namely, arrays of peptides and peptidomimetics, comprised of arrays of libraries of chemical compounds generated by using immobilized chemical compounds and arranged on a support for use in drug discovery and design] | SECTION 8 - CANCELLED | — |
| 009 | [ Scientific measuring and checking apparatus and instruments, namely, filters for use in drug discovery and design and membranes for use in drug discovery and design; Scientific apparatus and instruments, namely, filters for use in drug discovery and design and membranes for use in drug discovery and design comprised of peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules, immobilized chemical compounds, libraries of immobilized chemical compounds, arrays of peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleorides, peptide nucleic acids and locked nucleic acids and small molecules, arrays of libraries of chemical compounds immobilized on support, compounds generated by using immobilized chemical compounds, arrays of chemical compounds and libraries of chemical compounds which are immobilized on a support for use in drug discovery and design; Computer programs for synthesis and/or immobilization of chemical compounds, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules, of immobilized chemical compounds, arrays of libraries of chemical compounds immobilized on a support; Computer programs for the analysis of patterns on surfaces, namely, filters, membranes, and surfaces comprising chemicals, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules, for the analysis of immobilized chemical compounds, for the analysis of chemical compounds used in drug discovery and design, for the analysis of arrays of chemical compounds, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules, for the analysis of arrays of libraries of chemical compounds arranged on a support, for the analysis of compounds which were generated using immobilized chemical compounds, libraries of chemical compounds or arrays of chemical compounds, preferably those which are immobilized on a support; Computer programs for the screening of compounds, namely, enzymes, enzyme substrates, antibodies and antigens] | SECTION 8 - CANCELLED | — |
| 010 | [ computer programs for the syntheses and immobilization of chemical products used in industry and science, for the analysis of patterns on surfaces and for the screening of compounds, namely, enzymes, enzyme substrates, antibodies and antigens] | SECTION 8 - CANCELLED | — |
| 042 | Chemical research, namely, synthesis of chemical compounds for use in the field of pharmaceuticals, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules, immobilized chemical compounds; Arrays of chemical compounds, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules; Arrays of libraries of chemical compounds arranged on a support, compounds generated using immobilized chemical compounds, libraries of chemical compounds, or arrays of chemical compounds which are immobilized on a support; Synthesis of peptides with more than 50 amino acids, peptides with sterically hindered amino acids, peptides with distinct secondary structure and peptides being multiply antigenic; Chemical research, namely, immobilization of chemical compounds for use in the field of pharmaceuticals, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules; Chemical research, namely, immobilizing arrays of chemical compounds, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules; Chemical research, namely, immobilization of arrays of libraries of chemical compounds; Chemical research, namely, modification of peptides and proteins; transformation of biologically active peptides and peptidomimetics; Research in the field of synthesis and/or immobilization of chemical compounds for use in industry and science, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, [ nucleic acids, oligonucleotides, polynucleotides,] peptide nucleic acids [and locked nucleic acids and small molecules;] Immobilized chemical compounds of arrays of chemical compounds, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acid and small molecules; arrays of libraries of chemical compounds arranged on a support, of compounds generated using immobilized chemical compounds, libraries of chemical compounds or arrays of chemical compounds, preferably arranged on a support for use in the field of pharmaceuticals; Screening of interaction partners, namely, enzymes, enzyme substrates, antigens and antibodies; Development of enzyme inhibitors, namely, kinases; Development of lead structures for pharmaceutically active agents; Development of clinical, laboratory and medical diagnostics; screening and development of chemical compounds for use in industry and science, namely, peptides and peptidomimetics, amino acids, polypeptides, proteins, nucleic acids, oligonucleotides, polynucleotides, peptide nucleic acids and locked nucleic acids and small molecules; Arrays of libraries of chemical compounds arranged on a support, compounds generated by using immobilized chemical compounds, libraries of chemical compounds or arrays of chemical compounds, preferably immobilized on a support for use in the field of pharmaceuticals; Computer programming for any of the aforementioned | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Jerini Bio Tools GmbH
- Other trademarks owned by JERINI AG
- Other trademarks owned by JERINI AG
- Other trademarks owned by JERINI AG
- Other trademarks owned by JPT PEPTIDE TECHNOLOGIES GMBH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named SPOT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 27, 2025 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Dec 14, 2023 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Sep 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 27, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 27, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 27, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 27, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 11, 2014 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Dec 11, 2014 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Dec 11, 2014 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Dec 9, 2014 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Dec 22, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 4, 2011 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 4, 2011 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 29, 2010 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 13, 2010 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Dec 13, 2010 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Feb 3, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 3, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 24, 2007 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Oct 18, 2007 | PAPER RECEIVED | — | |
| Dec 14, 2004 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Dec 14, 2004 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 21, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 1, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 5, 2004 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 18, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2004 | PAPER RECEIVED | — | |
| Jun 3, 2004 | PAPER RECEIVED | — | |
| Apr 30, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 19, 2004 | PAPER RECEIVED | — | |
| Apr 19, 2004 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Apr 19, 2004 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Apr 12, 2004 | PAPER RECEIVED | — | |
| Apr 12, 2004 | PAPER RECEIVED | — | |
| Apr 1, 2004 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Feb 20, 2004 | CFIT | CASE FILE IN TICRS | — |
| Oct 6, 2003 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 5, 2003 | REIN | REINSTATED | — |
| Feb 6, 2003 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Jun 27, 2002 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 11, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 11, 2002 | PAPER RECEIVED | — | |
| Sep 10, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 27, 2001 | DOCK | ASSIGNED TO EXAMINER | — |